Adimmune Corp (4142) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH131057D
- Pages: 17
- October 2018
- Total Views:1167
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation's products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provides therapeutic nucleic acids, influenza vaccine, entrovirus 71 vaccine, and Japanese encephalitis vaccine. Adimmune offers such as seasonal flu vaccine plant, testing and analysis services, fill and finish services, quality assurance courses, and consulting services. The corporation offers product testing and analysis of quality of vaccines and biological products, and also offers other relevant testing services. It sells products through a network of distributors in Taiwan. Adimmune is headquartered in Taichung, Taiwan.
Adimmune Corp (4142)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adimmune Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Licensing Agreements 11
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Debt Offering 13
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp-Key Competitors 14
Adimmune Corp-Key Employees 15
Adimmune Corp-Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List Of Figure
List of Figures
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Adimmune Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp, Key Competitors 14
Adimmune Corp, Key Employees 15
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Adimmune Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation's products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provides therapeutic nucleic acids, influenza vaccine, entrovirus 71 vaccine, and Japanese encephalitis vaccine. Adimmune offers such as seasonal flu vaccine plant, testing and analysis services, fill and finish services, quality assurance courses, and consulting services. The corporation offers product testing and analysis of quality of vaccines and biological products, and also offers other relevant testing services. It sells products through a network of distributors in Taiwan. Adimmune is headquartered in Taichung, Taiwan.
Adimmune Corp (4142)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Adimmune Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Licensing Agreements 11
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Debt Offering 13
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp-Key Competitors 14
Adimmune Corp-Key Employees 15
Adimmune Corp-Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List Of Figure
List of Figures
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Adimmune Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adimmune Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adimmune Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adimmune Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Adimmune Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hualan Biological Engineering To Enter Into R&D Agreement With Adimmune 10
Valneva Enters into Licensing Agreement with Adimmune for Japanese Encephalitis Vaccine 11
Adimmune Enters into Licensing Agreement with National Health Research 12
Adimmune Raises USD47.5 Million in Private Placement of Bonds Due 2021 13
Adimmune Corp, Key Competitors 14
Adimmune Corp, Key Employees 15
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Adimmune Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.